;PMID: 10461422
;source_file_867.mrg
;Release 0.9 of PennBioIE
;Funded by NSF ITR EIA-0205448

;0)section:[e:0..42] = [t:0..42]
;1)sentence:[e:48..150] = [t:48..150]
;2)section:[e:154..212] = [t:154..212]
;3)section:[e:216..307] = [t:216..307]
;4)sentence:[e:311..322] = [t:311..322]
;5)sentence:[e:323..473] = [t:323..473]
;6)sentence:[e:474..633] = [t:474..633]
;7)sentence:[e:634..754] = [t:634..754]
;8)sentence:[e:755..899] = [t:755..899]
;9)sentence:[e:900..908] = [t:900..908]
;10)sentence:[e:909..1051] = [t:909..1051]
;11)sentence:[e:1052..1152] = [t:1052..1152]
;12)sentence:[e:1153..1277] = [t:1153..1277]
;13)sentence:[e:1278..1286] = [t:1278..1286]
;14)sentence:[e:1287..1574] = [t:1287..1574]
;15)sentence:[e:1575..1748] = [t:1575..1748]
;16)sentence:[e:1749..1805] = [t:1749..1805]
;17)sentence:[e:1806..1945] = [t:1806..1945]
;18)sentence:[e:1946..1957] = [t:1946..1957]
;19)sentence:[e:1958..2038] = [t:1958..2038]
;20)sentence:[e:2039..2095] = [t:2039..2095]
;21)section:[e:2099..2144] = [t:2099..2144]

;section 0 Span:0..42
;Korean J Intern Med. 1999 Jul;14(2):27-33.
(SEC
  (FRAG (JJ:[0..6] Korean) (NNPS:[7..8] J) (NNP:[9..15] Intern)
        (NNPS:[16..19] Med) (.:[19..20] .) (CD:[21..25] 1999)
        (CC:[26..33] Jul;14-LRB-) (CD:[33..34] 2) (-RRB-:[34..35] -RRB-)
        (CD:[35..38] :27) (HYPH:[38..39] -) (CD:[39..41] 33) (.:[41..42] .)))

;sentence 1 Span:48..150
;Protective effect of chlormethiazole, a sedative, against
;acetaminophen-induced  liver injury in mice.
;[69..84]:substance:"chlormethiazole"
;[88..96]:substance:"sedative"
;[106..119]:substance:"acetaminophen"
(SENT
  (NP-HLN
    (NP (JJ:[48..58] Protective) (NN:[59..65] effect))
    (PP (IN:[66..68] of)
      (NP
        (NP (NN:[69..84] chlormethiazole))
        (,:[84..85] ,)
        (NP (DT:[86..87] a) (NN:[88..96] sedative))))
    (,:[96..97] ,)
    (PP (IN:[98..105] against)
      (NP
        (ADJP (NN:[106..119] acetaminophen) (HYPH:[119..120] -)
              (VBN:[120..127] induced))
        (NN:[129..134] liver) (NN:[135..141] injury)))
    (PP-LOC (IN:[142..144] in)
      (NP (NNS:[145..149] mice)))
    (.:[149..150] .)))

;section 2 Span:154..212
;Lee HC, Jung SA, Jung HK, Yi SY, Kim DY, Moon IH, Park SS.
(SEC
  (FRAG (NNP:[154..157] Lee) (NNP:[158..160] HC) (,:[160..161] ,)
        (NNP:[162..166] Jung) (NNP:[167..169] SA) (,:[169..170] ,)
        (NNP:[171..175] Jung) (NNP:[176..178] HK) (,:[178..179] ,)
        (NNP:[180..182] Yi) (NNP:[183..185] SY) (,:[185..186] ,)
        (NNP:[187..190] Kim) (NNP:[191..193] DY) (,:[193..194] ,)
        (NNP:[195..199] Moon) (NNP:[200..202] IH) (NNP:[202..203] ,)
        (NNP:[204..208] Park) (NNP:[209..211] SS) (.:[211..212] .)))

;section 3 Span:216..307
;Department of Internal Medicine, Ewha Womans University College of Medicine, 
;Seoul, Korea.
(SEC
  (FRAG (NNP:[216..226] Department) (IN:[227..229] of) (NNP:[230..238] Internal)
        (NNP:[239..247] Medicine) (,:[247..248] ,) (DT:[249..253] Ewha)
        (NNP:[254..260] Womans) (NNP:[261..271] University)
        (NNP:[272..279] College) (IN:[280..282] of) (NNP:[283..291] Medicine)
        (,:[291..292] ,) (NNP:[294..299] Seoul) (,:[299..300] ,)
        (NNP:[301..306] Korea) (.:[306..307] .)))

;sentence 4 Span:311..322
;OBJECTIVES:
(SENT
  (NP (NNS:[311..321] OBJECTIVES) (::[321..322] :)))

;sentence 5 Span:323..473
;The hepatotoxicity of acetaminophen is not a result of the parent  compound
;but is mediated by its reactive metabolite N-acetyl-p-benzoquinone  imine.
;[345..358]:substance:"acetaminophen"
;[431..441]:substance:"metabolite"
;[442..472]:substance:"N-acetyl-p-benzoquinone  imine"
(SENT
  (S
    (NP-SBJ-1
      (NP (DT:[323..326] The) (NN:[327..341] hepatotoxicity))
      (PP (IN:[342..344] of)
        (NP (NN:[345..358] acetaminophen))))
    (VP
      (VP (VBZ:[359..361] is) (RB:[362..365] not)
        (NP-PRD
          (NP (DT:[366..367] a) (NN:[368..374] result))
          (PP (IN:[375..377] of)
            (NP (DT:[378..381] the) (NN:[382..388] parent)
                (NN:[390..398] compound)))))
      (CC:[399..402] but)
      (VP (VBZ:[403..405] is)
        (VP (VBN:[406..414] mediated)
          (NP-1 (-NONE-:[414..414] *))
          (PP (IN:[415..417] by)
            (NP-LGS
              (NP (PRP$:[418..421] its) (JJ:[422..430] reactive)
                  (NN:[431..441] metabolite))
              (NP (NN:[442..465] N-acetyl-p-benzoquinone) (NN:[467..472] imine)))))))
    (.:[472..473] .)))

;sentence 6 Span:474..633
;Cytochrome P4502E1 (CYP2E1) is the principal enzyme of this 
;biotransformation, which accounts for approximately 52% of the bioactivation
;in  human microsomes.
;[474..492]:cyp450:"Cytochrome P4502E1"
;[494..500]:cyp450:"CYP2E1"
;[519..525]:cyp450:"enzyme"
;[573..590]:quantitative-value:"approximately 52%"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[474..484] Cytochrome) (NN:[485..492] P4502E1))
      (NP (-LRB-:[493..494] -LRB-) (NN:[494..500] CYP2E1)
          (-RRB-:[500..501] -RRB-)))
    (VP (VBZ:[502..504] is)
      (NP-PRD
        (NP (DT:[505..508] the) (JJ:[509..518] principal) (NN:[519..525] enzyme))
        (PP (IN:[526..528] of)
          (NP
            (NP (DT:[529..533] this) (NN:[535..552] biotransformation))
            (,:[552..553] ,)
            (SBAR
              (WHNP-1 (WDT:[554..559] which))
              (S
                (NP-SBJ-1 (-NONE-:[559..559] *T*))
                (VP (VBZ:[560..568] accounts)
                  (PP-CLR (IN:[569..572] for)
                    (NP
                      (NP
                        (QP (RB:[573..586] approximately) (CD:[587..589] 52))
                        (NN:[589..590] %))
                      (PP (IN:[591..593] of)
                        (NP
                          (NP (DT:[594..597] the) (NN:[598..611] bioactivation))
                          (PP-LOC (IN:[612..614] in)
                            (NP (JJ:[616..621] human)
                                (NNS:[622..632] microsomes))))))))))))))
    (.:[632..633] .)))

;sentence 7 Span:634..754
;Recently, chlormethiazole a sedative drug, is reported to be  an efficient
;inhibitor of CYP2E1 activity in human beings.
;[644..659]:substance:"chlormethiazole"
;[662..675]:substance:"sedative drug"
;[709..718]:substance:"inhibitor"
;[722..728]:cyp450:"CYP2E1"
(SENT
  (S
    (ADVP-TMP (RB:[634..642] Recently))
    (,:[642..643] ,)
    (NP-SBJ-1
      (NP (NN:[644..659] chlormethiazole))
      (NP (DT:[660..661] a)
         (JJ:[662..670] sedative) (NN:[671..675] drug)))
    (,:[675..676] ,)
    (VP (VBZ:[677..679] is)
      (VP (VBN:[680..688] reported)
        (NP-1 (-NONE-:[688..688] *))
        (S
          (NP-SBJ-1 (-NONE-:[688..688] *))
          (VP (TO:[689..691] to)
            (VP (VB:[692..694] be)
              (NP-PRD
                (NP (DT:[696..698] an) (JJ:[699..708] efficient)
                    (NN:[709..718] inhibitor))
                (PP (IN:[719..721] of)
                  (NP (NN:[722..728] CYP2E1) (NN:[729..737] activity))))
              (PP-LOC (IN:[738..740] in)
                (NP (NN:[741..746] human) (NNS:[747..753] beings))))))))
    (.:[753..754] .)))

;sentence 8 Span:755..899
;In this study we  wished to evaluate whether chlormethiazole, an inhibitor of
;CYP2E1, could  prevent acetaminophen-induced liver injury in mice.
;[800..815]:substance:"chlormethiazole"
;[820..829]:substance:"inhibitor"
;[833..839]:cyp450:"CYP2E1"
;[856..869]:substance:"acetaminophen"
(SENT
  (S
    (PP (IN:[755..757] In)
      (NP (DT:[758..762] this) (NN:[763..768] study)))
    (NP-SBJ-1 (PRP:[769..771] we))
    (VP (VBD:[773..779] wished)
      (S
        (NP-SBJ-1 (-NONE-:[779..779] *))
        (VP (TO:[780..782] to)
          (VP (VB:[783..791] evaluate)
            (SBAR (IN:[792..799] whether)
              (S
                (NP-SBJ
                  (NP (NN:[800..815] chlormethiazole))
                  (,:[815..816] ,)
                  (NP
                    (NP (DT:[817..819] an) (NN:[820..829] inhibitor))
                    (PP (IN:[830..832] of)
                      (NP (NN:[833..839] CYP2E1)))))
                (,:[839..840] ,)
                (VP (MD:[841..846] could)
                  (VP (VB:[848..855] prevent)
                    (NP
                      (ADJP (NN:[856..869] acetaminophen) (HYPH:[869..870] -)
                            (VBN:[870..877] induced))
                      (NN:[878..883] liver) (NN:[884..890] injury))
                    (PP-LOC (IN:[891..893] in)
                      (NP (NNS:[894..898] mice)))))))))))
    (.:[898..899] .)))

;sentence 9 Span:900..908
;METHODS:
(SENT
  (NP (NNS:[900..907] METHODS) (::[907..908] :)))

;sentence 10 Span:909..1051
;Acetaminophen, at  doses ranging from 200 to 600 mg/kg, was injected into the
;peritoneum of female  C57BL/6 inbred mice fasted for four hours.
;[909..922]:substance:"Acetaminophen"
;[947..957]:quantitative-value:"200 to 600"
;[958..963]:quantitative-units:"mg/kg"
;[1040..1044]:quantitative-value:"four"
;[1045..1050]:quantitative-units:"hours"
(SENT
  (S
    (NP-SBJ-1
      (NP (NN:[909..922] Acetaminophen))
      (,:[922..923] ,)
      (PP (IN:[924..926] at)
        (NP
          (NP (NNS:[928..933] doses))
          (VP (VBG:[934..941] ranging)
            (PP (IN:[942..946] from)
              (NP
                (NP (CD:[947..950] 200)
                  (NML-3 (-NONE-:[950..950] *P*)))
                (PP-2 (-NONE-:[950..950] *P*))))
            (PP (TO:[951..953] to)
              (NP
                (NP (CD:[954..957] 600)
                  (NML-3 (NN:[958..960] mg)))
                (PP-2 (SYM:[960..961] /)
                  (NP (NN:[961..963] kg)))))))))
    (,:[963..964] ,)
    (VP (VBD:[965..968] was)
      (VP (VBN:[969..977] injected)
        (NP-1 (-NONE-:[977..977] *))
        (PP (IN:[978..982] into)
          (NP
            (NP (DT:[983..986] the) (NN:[987..997] peritoneum))
            (PP (IN:[998..1000] of)
              (NP
                (NP (JJ:[1001..1007] female)
                  (NML (NN:[1009..1014] C57BL) (SYM:[1014..1015] /)
                       (CD:[1015..1016] 6))
                  (JJ:[1017..1023] inbred) (NNS:[1024..1028] mice))
                (VP (VBN:[1029..1035] fasted)
                  (NP (-NONE-:[1035..1035] *))
                  (PP-TMP (IN:[1036..1039] for)
                    (NP (CD:[1040..1044] four) (NNS:[1045..1050] hours))))))))))
    (.:[1050..1051] .)))

;sentence 11 Span:1052..1152
;Chlormethiazole (60 mg/kg) or 5%  dextrose water was given 30 min before or 2
;h after acetaminophen.
;[1052..1067]:substance:"Chlormethiazole"
;[1069..1071]:quantitative-value:"60"
;[1072..1077]:quantitative-units:"mg/kg"
;[1082..1084]:quantitative-value:"5%"
;[1086..1100]:substance:"dextrose water"
;[1111..1113]:quantitative-value:"30"
;[1114..1117]:quantitative-units:"min"
;[1128..1129]:quantitative-value:"2"
;[1130..1131]:quantitative-units:"h"
;[1138..1151]:substance:"acetaminophen"
(SENT
  (S
    (NP-SBJ-2
      (NP (NN:[1052..1067] Chlormethiazole)
        (PRN (-LRB-:[1068..1069] -LRB-)
          (NP
            (NP (CD:[1069..1071] 60) (NN:[1072..1074] mg))
            (PP (SYM:[1074..1075] /)
              (NP (NN:[1075..1077] kg))))
          (-RRB-:[1077..1078] -RRB-)))
      (CC:[1079..1081] or)
      (NP
        (NML
          (NML (CD:[1082..1083] 5) (NN:[1083..1084] %))
          (NN:[1086..1094] dextrose))
        (NN:[1095..1100] water)))
    (VP (VBD:[1101..1104] was)
      (VP (VBN:[1105..1110] given)
        (NP-2 (-NONE-:[1110..1110] *))
        (PP-TMP
          (PP
            (NP-ADV (CD:[1111..1113] 30) (NN:[1114..1117] min))
            (IN:[1118..1124] before)
            (NP-1 (-NONE-:[1124..1124] *RNR*)))
          (CC:[1125..1127] or)
          (PP
            (NP-ADV (CD:[1128..1129] 2) (NN:[1130..1131] h))
            (IN:[1132..1137] after)
            (NP-1 (-NONE-:[1137..1137] *RNR*)))
          (NP-1 (NN:[1138..1151] acetaminophen)))))
    (.:[1151..1152] .)))

;sentence 12 Span:1153..1277
;Serum  aminotransferase activities, histologic index score, survival rate and
;hepatic  malondialdehyde levels were compared.
;[1153..1176]:substance:"Serum  aminotransferase"
;[1240..1255]:substance:"malondialdehyde"
(SENT
  (S
    (NP-SBJ-1
      (NP
         (NN:[1153..1158] Serum) (NN:[1160..1176] aminotransferase)
        (NNS:[1177..1187] activities))
      (,:[1187..1188] ,)
      (NP (JJ:[1189..1199] histologic) (NN:[1200..1205] index)
          (NN:[1206..1211] score))
      (,:[1211..1212] ,)
      (NP (NN:[1213..1221] survival) (NN:[1222..1226] rate))
      (CC:[1227..1230] and)
      (NP (JJ:[1231..1238] hepatic) (NN:[1240..1255] malondialdehyde)
          (NNS:[1256..1262] levels)))
    (VP (VBD:[1263..1267] were)
      (VP (VBN:[1268..1276] compared)
        (NP-1 (-NONE-:[1276..1276] *))))
    (.:[1276..1277] .)))

;sentence 13 Span:1278..1286
;RESULTS:
(SENT
  (NP (NNS:[1278..1285] RESULTS) (::[1285..1286] :)))

;sentence 14 Span:1287..1574
;Pretreatment with chlormethiazole  30 min before 400 mg/kg of acetaminophen
;completely inhibited  acetaminophen-induced liver injury (median 118.5 U/L,
;range 75 to 142 vs. 14,070  U/L, range 5980 to 27,680 for AST; 49 U/L, range
;41 to 64 vs. 15,330 U/L, range  13,920 to 15,940 for ALT).
;[1305..1320]:substance:"chlormethiazole"
;[1322..1324]:quantitative-value:"30"
;[1325..1328]:quantitative-units:"min"
;[1336..1339]:quantitative-value:"400"
;[1340..1345]:quantitative-units:"mg/kg"
;[1349..1362]:substance:"acetaminophen"
;[1385..1398]:substance:"acetaminophen"
;[1428..1433]:quantitative-value:"118.5"
;[1434..1437]:quantitative-units:"U/L"
;[1445..1454]:quantitative-value:"75 to 142"
;[1459..1465]:quantitative-value:"14,070"
;[1467..1470]:quantitative-units:"U/L"
;[1478..1492]:quantitative-value:"5980 to 27,680"
;[1497..1500]:quantitative-name:"AST"
;[1502..1504]:quantitative-value:"49"
;[1505..1508]:quantitative-units:"U/L"
;[1516..1524]:quantitative-value:"41 to 64"
;[1529..1535]:quantitative-value:"15,330"
;[1536..1539]:quantitative-units:"U/L"
;[1548..1564]:quantitative-value:"13,920 to 15,940"
;[1569..1572]:quantitative-name:"ALT"
(SENT
  (S
    (NP-SBJ
      (NP (NN:[1287..1299] Pretreatment))
      (PP (IN:[1300..1304] with)
        (NP (NN:[1305..1320] chlormethiazole)))
      (PP-TMP
        (NP-ADV (CD:[1322..1324] 30) (NN:[1325..1328] min))
        (IN:[1329..1335] before)
        (NP
          (NP (CD:[1336..1339] 400) (NN:[1340..1342] mg))
          (PP (SYM:[1342..1343] /)
            (NP (NN:[1343..1345] kg)))
          (PP (IN:[1346..1348] of)
            (NP (NN:[1349..1362] acetaminophen))))))
    (ADVP (RB:[1363..1373] completely))
    (VP (VBD:[1374..1383] inhibited)
      (NP
        (ADJP (NN:[1385..1398] acetaminophen) (HYPH:[1398..1399] -)
              (VBN:[1399..1406] induced))
        (NN:[1407..1412] liver) (NN:[1413..1419] injury))
      (PRN (-LRB-:[1420..1421] -LRB-)
        (FRAG
          (S
            (NP-SBJ (NN:[1421..1427] median))
            (NP-PRD (CD:[1428..1433] 118.5)
               (NN:[1434..1435] U) (SYM:[1435..1436] /) (NN:[1436..1437] L)))
          (,:[1437..1438] ,)
          (S
            (NP-SBJ (NN:[1439..1444] range))
            (NP-PRD
              (QP (CD:[1445..1447] 75) (TO:[1448..1450] to)
                  (CD:[1451..1454] 142)))
            (PP (IN:[1455..1458] vs.)
              (NP (CD:[1459..1465] 14,070)
                 (NN:[1467..1468] U) (SYM:[1468..1469] /) (NN:[1469..1470] L))))
          (,:[1470..1471] ,)
          (S
            (NP-SBJ (NN:[1472..1477] range))
            (NP-PRD
              (QP (CD:[1478..1482] 5980) (TO:[1483..1485] to)
                  (CD:[1486..1492] 27,680)))
            (PP (IN:[1493..1496] for)
              (NP (NN:[1497..1500] AST))))
          (::[1500..1501] ;)
          (FRAG
            (NP (CD:[1502..1504] 49)
               (NN:[1505..1506] U) (SYM:[1506..1507] /) (NN:[1507..1508] L))
            (,:[1508..1509] ,)
            (S
              (NP-SBJ (NN:[1510..1515] range))
              (NP-PRD
                (QP (CD:[1516..1518] 41) (TO:[1519..1521] to)
                    (CD:[1522..1524] 64)))
              (PP (IN:[1525..1528] vs.)
                (NP (CD:[1529..1535] 15,330)
                   (NN:[1536..1537] U) (SYM:[1537..1538] /) (NN:[1538..1539] L)))))
          (,:[1539..1540] ,)
          (S
            (NP-SBJ (NN:[1541..1546] range))
            (NP-PRD (CD:[1548..1554] 13,920) (TO:[1555..1557] to)
                    (CD:[1558..1564] 15,940))
            (PP (IN:[1565..1568] for)
              (NP (NN:[1569..1572] ALT)))))
        (-RRB-:[1572..1573] -RRB-)))
    (.:[1573..1574] .)))

;sentence 15 Span:1575..1748
;In mice receiving chlormethiazole 2 h after  acetaminophen, the mean AST and
;ALT levels were also less elevated, reaching  only 20% of the value of
;acetaminophen-only group.
;[1593..1608]:substance:"chlormethiazole"
;[1609..1610]:quantitative-value:"2"
;[1611..1612]:quantitative-units:"h"
;[1620..1633]:substance:"acetaminophen"
;[1644..1647]:quantitative-name:"AST"
;[1652..1655]:quantitative-name:"ALT"
;[1703..1706]:quantitative-value:"20%"
;[1723..1736]:substance:"acetaminophen"
(SENT
  (S
    (PP-LOC (IN:[1575..1577] In)
      (NP
        (NP (NNS:[1578..1582] mice))
        (VP (VBG:[1583..1592] receiving)
          (NP (NN:[1593..1608] chlormethiazole))
          (PP-TMP
            (NP-ADV (CD:[1609..1610] 2) (NN:[1611..1612] h))
            (IN:[1613..1618] after)
            (NP (NN:[1620..1633] acetaminophen))))))
    (,:[1633..1634] ,)
    (NP-SBJ (DT:[1635..1638] the)
      (NML
        (NML
          (ADJP-2 (JJ:[1639..1643] mean))
          (NN:[1644..1647] AST)
          (NML-1 (-NONE-:[1647..1647] *P*)))
        (CC:[1648..1651] and)
        (NML
          (ADJP-2 (-NONE-:[1651..1651] *P*))
          (NN:[1652..1655] ALT)
          (NML-1 (NNS:[1656..1662] levels)))))
    (VP (VBD:[1663..1667] were)
      (ADVP (RB:[1668..1672] also))
      (ADJP-PRD (RBR:[1673..1677] less) (VBN:[1678..1686] elevated))
      (,:[1686..1687] ,)
      (S-ADV
        (NP-SBJ (-NONE-:[1687..1687] *))
        (VP (VBG:[1688..1696] reaching)
          (NP
            (NP
              (QP (RB:[1698..1702] only) (CD:[1703..1705] 20))
              (NN:[1705..1706] %))
            (PP (IN:[1707..1709] of)
              (NP
                (NP (DT:[1710..1713] the) (NN:[1714..1719] value))
                (PP (IN:[1720..1722] of)
                  (NP
                    (ADVP (NN:[1723..1736] acetaminophen) (HYPH:[1736..1737] -)
                          (RB:[1737..1741] only))
                    (NN:[1742..1747] group)))))))))
    (.:[1747..1748] .)))

;sentence 16 Span:1749..1805
;These protective effects were  confirmed histologically.
(SENT
  (S
    (NP-SBJ-1 (DT:[1749..1754] These) (JJ:[1755..1765] protective)
              (NNS:[1766..1773] effects))
    (VP (VBD:[1774..1778] were)
      (VP (VBN:[1780..1789] confirmed)
        (NP-1 (-NONE-:[1789..1789] *))
        (ADVP (RB:[1790..1804] histologically))))
    (.:[1804..1805] .)))

;sentence 17 Span:1806..1945
;Whereas more than 50% of mice died at 500 mg/kg of  acetaminophen, all the
;mice pretreated with chlormethiazole survived at the same  dose.
;[1814..1827]:quantitative-value:"more than 50%"
;[1844..1847]:quantitative-value:"500"
;[1848..1853]:quantitative-units:"mg/kg"
;[1858..1871]:substance:"acetaminophen"
;[1902..1917]:substance:"chlormethiazole"
(SENT
  (S
    (SBAR-ADV (IN:[1806..1813] Whereas)
      (S
        (NP-SBJ
          (NP
            (QP (JJR:[1814..1818] more) (IN:[1819..1823] than)
                (CD:[1824..1826] 50))
            (NN:[1826..1827] %))
          (PP (IN:[1828..1830] of)
            (NP (NNS:[1831..1835] mice))))
        (VP (VBD:[1836..1840] died)
          (PP (IN:[1841..1843] at)
            (NP
              (NP (CD:[1844..1847] 500) (NN:[1848..1850] mg))
              (PP (SYM:[1850..1851] /)
                (NP (NN:[1851..1853] kg)))
              (PP (IN:[1854..1856] of)
                (NP (NN:[1858..1871] acetaminophen))))))))
    (,:[1871..1872] ,)
    (NP-SBJ
      (NP (PDT:[1873..1876] all) (DT:[1877..1880] the) (NNS:[1881..1885] mice))
      (VP (VBN:[1886..1896] pretreated)
        (NP (-NONE-:[1896..1896] *))
        (PP-MNR (IN:[1897..1901] with)
          (NP (NN:[1902..1917] chlormethiazole)))))
    (VP (VBD:[1918..1926] survived)
      (PP (IN:[1927..1929] at)
        (NP (DT:[1930..1933] the) (JJ:[1934..1938] same) (NN:[1940..1944] dose))))
    (.:[1944..1945] .)))

;sentence 18 Span:1946..1957
;CONCLUSION:
(SENT
  (NP (NN:[1946..1956] CONCLUSION) (::[1956..1957] :)))

;sentence 19 Span:1958..2038
;Chlormethiazole effectively reduces acetaminophen-induced  liver injury in
;mice.
;[1958..1973]:substance:"Chlormethiazole"
;[1994..2007]:substance:"acetaminophen"
(SENT
  (S
    (NP-SBJ (NN:[1958..1973] Chlormethiazole))
    (ADVP (RB:[1974..1985] effectively))
    (VP (VBZ:[1986..1993] reduces)
      (NP
        (ADJP (NN:[1994..2007] acetaminophen) (HYPH:[2007..2008] -)
              (VBN:[2008..2015] induced))
        (NN:[2017..2022] liver) (NN:[2023..2029] injury))
      (PP-LOC (IN:[2030..2032] in)
        (NP (NNS:[2033..2037] mice))))
    (.:[2037..2038] .)))

;sentence 20 Span:2039..2095
;Further studies are needed to assess its role in humans.
(SENT
  (S
    (NP-SBJ-1 (JJ:[2039..2046] Further) (NNS:[2047..2054] studies))
    (VP (VBP:[2055..2058] are)
      (VP (VBN:[2059..2065] needed)
        (NP-1 (-NONE-:[2065..2065] *))
        (S-PRP
          (NP-SBJ (-NONE-:[2065..2065] *))
          (VP (TO:[2066..2068] to)
            (VP (VB:[2069..2075] assess)
              (NP
                (NP (PRP$:[2076..2079] its) (NN:[2080..2084] role))
                (PP-LOC (IN:[2085..2087] in)
                  (NP (NNS:[2088..2094] humans)))))))))
    (.:[2094..2095] .)))

;section 21 Span:2099..2144
;PMID: 10461422 [PubMed - indexed for MEDLINE]
(SEC
  (FRAG (NNP:[2099..2103] PMID) (::[2103..2104] :) (CD:[2105..2113] 10461422)
        (IN:[2114..2115] -LSB-) (NNP:[2115..2121] PubMed) (HYPH:[2122..2123] -)
        (JJ:[2124..2131] indexed) (IN:[2132..2135] for)
        (NNP:[2136..2144] MEDLINE-RSB-)))
